Cheap Stocks

Dear Mr. Berko: My wife and I have $7,000, and we’d like to take a real gamble and buy three or four stocks that sell for less than $10 a share. If we lose, we lose; we won’t be bitter about it. But we think it would be exciting to follow the stocks, chart the price changes each day and be involved in some risky companies that could double, triple or become worthless. We asked our stockbroker for several names, but he’s a goody-two-shoes. He’s been in the business for only two years, and he only recommends stocks that his firm recommends. However, my wife’s individual retirement account and my IRA are up nearly 8 percent in 18 months, and we’re pleased. — SL, Fort Lauderdale, Fla.
Dear SL: The reason a stock trades at the price it does today is that right now, that price is the consensus of what thousands of knowledgeable buyers and thousands of knowledgeable sellers believe it’s worth. And it’s not worth a pfennig more. I know very little about cheap stocks, so I called my old pal Huckleberry Ginsberg, CSA (cheap stock analyst). Huckleberry, after he was refused admission to the Academy of Graduate Embalmers of Georgia, decided to become a certified CSA and studied under Bernie Madoff, Jordan Belfort, Andrew Fastow and Michael Milken. Over the years, I’ve asked Huck to help a few readers like you folks who want to toss the dice. The following are Huck’s recommendations, which he says could either zoom and boom or crash and smash.
Vivus (VVUS-$1.19), founded in 1991, is a $125 million-revenue biopharmaceutical company that is producing innovative next-generation therapeutics for obesity, diabetes and sexual health. Two recent drugs — Qsymia, the first drug for obesity approved by the Food and Drug Administration in 13 years, and Stendra, an amazingly effective drug for erectile dysfunction — have impressive potential. And it seems that Qsymia may also be approved for sleep apnea, diabetes and fatty liver disease. A third impressive drug — Tacrolimus, which is for pulmonary arterial hypertension — just successfully completed the phase 2 process. These drugs may provide VVUS with a significant cash flow stream in the near future. VVUS traded in the high $30s after coming public in 1997 and may make a profit this year. Zacks has a “strong buy” recommendation on it, and Thomson Reuters gives it an “outperform” rating.
Huckleberry also likes Banco Santander (SAN-$6.63). SAN was an unmitigated disaster during and after the Great Recession. Low interest rates, collapsing real estate prices and high unemployment drop-kicked SAN to $3.50, down 70 percent from its five-year high. It has recovered by about 3 points since then. New management smartly cut costs and closed 18 percent of its Spanish branches. SAN, a $51 billion-revenue bank with worldwide offices, derives 45 percent of its profits from the relatively strong economies in Mexico, the U.K. and the U.S. The 24-cent dividend yields 3.4 percent. Huck says it’s a $10 stock.
Radiant Logistics (RLGT-$5.48), founded in 2007, is a third-party logistics company providing multi-modal transportation solutions and services in the U.S. and Canada. RLGT’s clients — consumer goods companies, food and beverage companies, manufacturing companies and retail companies — are served from 18 strategically located offices. This profitable $780 million-revenue company contracts with over 11,000 transportation companies — including motor carriers, railroads, ocean lines and airlines — as part of its carrier network. Three- to five-year earnings growth is projected to be between 18 and 22 percent. Ten years ago, RLGT traded at 50 cents a share. Today most analysts have solid “buy” ratings on the stock.
I wish you enormous luck.
Please address your financial questions to Malcolm Berko, P.O. Box 8303, Largo, FL 33775, or email him at mjberko@yahoo.com. To find out more about Malcolm Berko and read features by other Creators Syndicate writers and cartoonists, visit the Creators Syndicate website at www.creators.com.

You May Also Like

SMART Program Highlights Collaboration Between Broward Public School District and Local Businesses

Broward voters approved The funding through a bond referendum in November 2014.

CBRE Analysis Reveals Growth in Life Sciences Research Talent in South Florida

Miami/Fort Lauderdale ranks among the top 25 U.S. life sciences labor markets.

Habitat for Humanity of Greater Palm Beach County Hosts Kickoff Party for CEO Build 2023

Participants can learn ways to get involved as a CEO Builder or Corporate Sponsor.

South Florida Manufacturers Association Holds 63rd Annual Meeting and Made in South Florida Showcase

The organization is the region’s leading resource for manufacturing companies.

Other Posts

Breaking News: Lifestyle Media Group is Honored by the FMA at the Charlie Awards

South Florida Business & Wealth and Tampa Bay Business & Wealth Win First-Place Awards.

The Success of a Region Is Signaled by One Data Point at a Time

A letter from Editor-in-Chief Drew Limsky.

Denise Rubin to Feature Exclusive Real Estate Listing on TV

Rubin has sold an array of multi-million dollar homes and condos in the South Florida market.

Chef and Bestselling Author Lenore Nolan Ryan CoAuthors Book on Life and Business

Ryan coauthored the book with Jack Canfield and other leading professionals.

Drew Limsky

Drew Limsky



Drew Limsky joined Lifestyle Media Group in August 2020 as Editor-in-Chief of South Florida Business & Wealth. His first issue of SFBW, October 2020, heralded a reimagined structure, with new content categories and a slew of fresh visual themes. “As sort of a cross between Forbes and Robb Report, with a dash of GQ and Vogue,” Limsky says, “SFBW reflects South Florida’s increasingly sophisticated and dynamic business and cultural landscape.”

Limsky, an avid traveler, swimmer and film buff who holds a law degree and Ph.D. from New York University, likes to say, “I’m a doctor, but I can’t operate—except on your brand.” He wrote his dissertation on the nonfiction work of Joan Didion. Prior to that, Limsky received his B.A. in English, summa cum laude, from Emory University and earned his M.A. in literature at American University in connection with a Masters Scholar Award fellowship.

Limsky came to SFBW at the apex of a storied career in journalism and publishing that includes six previous lead editorial roles, including for some of the world’s best-known brands. He served as global editor-in-chief of Lexus magazine, founding editor-in-chief of custom lifestyle magazines for Cadillac and Holland America Line, and was the founding editor-in-chief of Modern Luxury Interiors South Florida. He also was the executive editor for B2B magazines for Acura and Honda Financial Services, and he served as travel editor for Conde Nast. Magazines under Limsky’s editorship have garnered more than 75 industry awards.

He has also written for many of the country’s top newspapers and magazines, including The New York Times, Washington Post, Los Angeles Times, Miami Herald, Boston Globe, USA Today, Worth, Robb Report, Afar, Time Out New York, National Geographic Traveler, Men’s Journal, Ritz-Carlton, Elite Traveler, Florida Design, Metropolis and Architectural Digest Mexico. His other clients have included Four Seasons, Acqualina Resort & Residences, Yahoo!, American Airlines, Wynn, Douglas Elliman and Corcoran. As an adjunct assistant professor, Limsky has taught journalism, film and creative writing at the City University of New York, Pace University, American University and other colleges.